| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.037 | 0.5 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | -0.1 | 0.5 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.043 | 0.5 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |